• 1
    Mosmann TR & Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1994; 7: 14573.
  • 2
    Mosmann TR & Sad S. The expanding universe of T cell subsets—Th1, Th2 and more. Immunol Today 1996; 17: 13846.DOI: 10.1016/0167-5699(96)80606-2
  • 3
    Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994; 12: 22757.
  • 4
    Adkis M, Simon HU, Weigl L, Kreyden O, Blaser K & Adkis CA. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999; 163: 46675.
  • 5
    Clerici M & Shearer GM. A Th1/ Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 10711.
  • 6
    Wegmann TG, Lin H, Guilbert L & Mosmann TL. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993; 14: 3536.
  • 7
    Lin H, Mosmann TR, Guilbert L, Tuntipopipat S & Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal–fetal interface. J Immunol 1993; 151: 456273.
  • 8
    Delassus S, Coutinho GC, Saucier C, Darche S & Kourilsky P. Deferential cytokine expression in maternal blood and placenta during murine gestation. J Immunol 1994; 152: 241120.
  • 9
    Chaouat G, Meliani AA, Martal J, Raghupathy R, Elliot J, Mosmann T & Wegmann T. IL-10 prevents naturally occurring fetal loss in the CBAxDBA/2 mating combination, and local defect in IL-10 production in this abortion-prone combination is occurred by in vivo injection of IFN-t. J Immunol 1995; 154: 42618.
  • 10
    Krishnan L, Guilbert LJ, Russell AS, Wegmann TG, Mosmann TG & Belosevic M. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFNγ responses and increased production of T helper 2 cytokines. J Immunol 1996; 156: 64452.
  • 11
    Krishnan L, Guilbert LJ, Wegmann TG, Belosevic M & Mosmann TR. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. J Immunol 1996; 156: 65362.
  • 12
    Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E & Clerici M. Characterization of type 1 and type 2 cytokine profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106: 12733.
  • 13
    Matthiesen L, Ekerfelt C, Berg G & Ernerudh J. Increased numbers of circulating interferon-gamma and interleukin-4-secreting cells during normal pregnancy. Am J Reprod Immunol 1998; 39: 3627.
  • 14
    Russell AS, Johnston C, Crew C & Maksymowych WP. Evidence for reduced Th1 function in normal pregnancy: a hypothesis for the remission of rheumatoid arthritis. J Rheumatol 1997; 24: 104550.
  • 15
    Piccinni M-P, Beloni L, Livi C, Maggi E, Scarselli G & Romagnani S. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nature Med 1998; 4: 10204.
  • 16
    Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H & Narita N. Distribution of Th1, Th2 and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reprod Immunol 1999; 42: 2405.
  • 17
    Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H & Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117: 5505.DOI: 10.1046/j.1365-2249.1999.00997.x
  • 18
    Picker LJ, Singh MK, Zdraveski S, Treer JR, Waldrop SL, Bergstresser PR & Maino VC. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86: 140819.
  • 19
    Nagata K, Tanaka K & Ogawa K et al. Selective expression of a novel surface molecule by human Th2 cells in vivo. J Immunol 1999; 162: 127886.
  • 20
    Nagata K, Hirai H, Tanaka K, Ogawa K, Aso T, Sugamura K, Nakamura M & Takano S. CRTH2 an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Letters 1999; 459: 1959.DOI: 10.1016/s0014-5793(99)01251-x
  • 21
    Saito S, Nishikawa K, Mori T, Narita N, Enomoto M & Ichijo M. Expression of activation CD69, HLA-DR, interleukin-2 receptor-alpha (IL-2Rα) and IL-2Rβ on T cells of human decidua at an early stage of pregnancy. Immunology 1992; 75: 7102.
  • 22
    Nishikawa K, Saito S & Morii T et al. Accumulation of CD16CD56+ natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua. Int Immunol 1991; 3: 74350.
  • 23
    Annunziato F, Manetti R & Tomasevic I et al. Expression and release of LAG-3-encoded protein by human CD4+ T cells are associated with IFN-gamma production. FASEB J 1996; 10: 76976.
  • 24
    Del Prete G, De Carli M & Almerigogna F et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995; 9: 8186.
  • 25
    Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C & Rothman P. Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 1995; 269: 2457.
  • 26
    Austrup F, Vestweber D & Borges E et al. P- and E-selection mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 1997; 385: 8183.
  • 27
    Szabo SJ, Dighe AS, Gubler U & Murphy KM. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997; 185: 81724.
  • 28
    Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C & Dayer JM. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 3445.DOI: 10.1038/34812
  • 29
    Sallusto F, Lnzavecchia A & Mackay CR. Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 1998; 19: 56874.DOI: 10.1016/s0167-5699(98)01346-2
  • 30
    Kim CH & Broxmeyer HE. Chemokines. Signal lamps for trafficking of T and B cells for development and effector function. J Leuk Biol 1999; 65: 615.
  • 31
    Loetscher P, Uguccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C & Dayer J-M. CCR5 is characteristic of Th1 lymphocytes. Nature 1998; 391: 3445.DOI: 10.1038/34812
  • 32
    Sallusto F, Lenig D, Mackay CR & Lanzavecchia A. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 1998; 187: 87583.
  • 33
    Sallusto F, Mackay CR & Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997; 277: 20057.DOI: 10.1126/science.277.5334.2005
  • 34
    Bonecchi R, Bianchi G & Bordignon PP et al. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1 s) and Th2s. J Exp Med 1998; 187: 12934.
  • 35
    Imai T, Nagira M & Takagi S et al. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 1999; 11: 8188.DOI: 10.1093/intimm/11.1.81
  • 36
    Zingoni A, Soto H & Hedrick JA et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998; 161: 54751.
  • 37
    Bernardini G, Hedrick J & Sozzani S et al. Identification of the CC chemokines TARC and macrophage inflammatory protein-1 beta as novel functional ligands for the CCR8 receptor. Eur J Immunol 1998; 28: 5828.DOI: 10.1002/(sici)1521-4141(199802)28:02<582::aid-immu582>;2-1
  • 38
    Annunziato F, Cosmi L, Galli G, Beltrame C, Romagnani P, Manetti R, Romagnani S & Maggi E. Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. J Leuk Biol 1999; 65: 6919.
  • 39
    Saito S, Nishikawa K, Morii T, Narita N, Enomoto M, Ito A & Ichijo M. A study of CD45RA and CD29 antigen expression on human decidual T cells in an early stage of pregnancy. Immunol Letters 1994; 40: 1937.
  • 40
    Hamai Y, Fuii T, Yamashita T, Nishina H, Kozuma S, Mikami Y & Taketani Y. Evidence for an elevation in serum interleukin-2 and tumor necrosis factor-α levels before the clinical manifestations of preeclampsia. Am J Reprod Immunol 1997; 38: 8993.